Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, as represented by the Secretary, Department of Health”
1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10087148
Quinazolines as biogenic amine transport modulators
granted -
US 10087230
Murine anti-NY-ESO-1 T cell receptors
granted -
US 10077296
Methods and compositions for the treatment and prevention of cancer
granted -
US 10076535
Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing
granted -
US 10072070
Potent anti-influenza A neuraminidase subtype N1 antibody
granted -
US 10072078
M971 chimeric antigen receptors
granted -
US 10071945
Nuclear receptor modulators and their use for the treatment and prevention of cancer
granted -
US 10058559
Treatment or prevention of an intestinal disease or disorder
granted -
US 10058602
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
granted -
US 10051880
Hydroxybutyrate ester and medical use thereof
granted -
US 10053503
Monoclonal antibodies that neutralize anthrax toxins
granted -
US 10047401
Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer
granted -
US 10047122
Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
granted -
US 10046012
Multipotent postnatal stem cells from human periodontal ligament and uses thereof
granted -
US 10047147
Neutralizing GP41 antibodies and their use
granted -
US 10047148
Neutralizing GP41 antibodies and their use
granted -
US 10035832
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
granted -
US 10035848
Antibody targeting cell surface deposited complement protein C3d and use thereof
granted -
US 10036020
Compositions and methods for inhibiting JC virus (JCV)
granted -
US 10035845
Neutralizing antibodies to HIV-1 and their use
granted -
US 10035833
Vascular endothelial growth factor antagonists and methods of making
granted -
US 10035844
Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein
granted -
US 10017762
Compositions and methods for treating or preventing lupus
granted -
US 10017516
BMP inhibitors and methods of use thereof
granted